ArticleThe Journal of antimicrobial chemotherapy2020

Tedizolid is a promising antimicrobial option for the treatment of Staphylococcus aureus infections in cystic fibrosis patients.

Melanie Roch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.